Dataset: Comparison of mRNA expression in circulating T-cells from patients with severe asthma
Comparison of mRNA expression showed widespread changes in the circulating CD8+ but not CD4+ T-cells from patients with severe asthma. No...
Comparison of mRNA expression showed widespread changes in the circulating CD8+ but not CD4+ T-cells from patients with severe asthma. No changes were observed in the CD4+ and CD8+ T-cells in non-severe asthmatics versus healthy controls. Bioinformatics analysis showed that the changes in CD8+ T-cell mRNA expression were associated with multiple pathways involved in T-cell activation. As with mRNAs, we also observed widespread changes in expression of non-coding RNA species including natural antisense, pseudogenes, intronic long ncRNAs and long intergenic long ncRNAs in CD8+ T-cells from severe asthmatics. Measurement of the miRNA expression profile showed selective down-regulation of miR-28-5p in CD8+ T-cells and reduction of miR-146a and miR-146b in both CD4+ and CD8+ T-cells. mRNA samples were collected from circulating CD4+ and CD8+ T-cells from healthy donors as well as donors with severe and non-severe asthma.
- Species:
- human
- Samples:
- 40
- Source:
- E-GEOD-31773
- Updated:
- Dec.12, 2014
- Registered:
- Sep.16, 2014
Sample | MEDICATION | FVC (% PREDICTED) | FEV1 (% PREDICTED) | GENDER | BATCH | AGE (YEARS) | PATIENT ID | CELL TYPE |
---|---|---|---|---|---|---|---|---|
GSM788299 | Becotide, Ventolin | 98 | 82 | male | 2 | 23 | Non_severe_1 | CD4+ T-cells |
GSM788300 | flixotide | 92 | 87 | female | 2 | 44 | Non_severe_2 | CD4+ T-cells |
GSM78830 | Becotide, Ventolin | 89 | 77 | male | 2 | 35 | Non_severe_3 | CD4+ T-cells |
GSM788302 | Salbutamol | 81 | 84 | female | 2 | 23 | Non_severe_4 | CD4+ T-cells |
GSM788303 | None | 76 | 78 | male | 1 | 39 | Control_1 | CD4+ T-cells |
GSM788304 | None | 107 | 103 | female | 1 | 25 | Control_2 | CD4+ T-cells |
GSM788305 | None | 115 | 105 | female | 1 | 26 | Control_3 | CD4+ T-cells |
GSM788306 | None | 105 | 92 | male | 1 | 46 | Control_4 | CD4+ T-cells |
GSM788307 | None | 77 | 78 | male | 1 | 33 | Control_5 | CD4+ T-cells |
GSM788308 | None | 115 | 116 | female | 1 | 33 | Control_6 | CD4+ T-cells |
GSM788309 | None | 96 | 85 | female | 1 | 31 | Control_7 | CD4+ T-cells |
GSM788310 | None | 111 | 111 | male | 1 | 56 | Control_8 | CD4+ T-cells |
GSM7883 | Flixotide 500mcg 2pbd,Oxis 12 1pbd,Loratadine 1 tab od,Beconase 2pbd | 105 | 82 | female | 1 | 55 | Severe_1 | CD4+ T-cells |
GSM788312 | Prednisolone 8mg - 1mg for 5wks(stopped 30/5/08),seretide 500mcg 1pbd,Singular 10mg bd,Phyllocontin 225mg am 450mg pm,Ventolin prn | 101 | 105 | female | 1 | 21 | Severe_2 | CD4+ T-cells |
GSM788313 | prednisolone 15mg od,Seretide 500mcg 2pbd,Montelukast 10mg nocte,Ventolin prn,Phyllocontin 450mg bd,Flixonase od | 113 | 98 | male | 1 | 32 | Severe_3 | CD4+ T-cells |
GSM788314 | Prednisolone 10mg od,Spiriva 18mcg od,Methotrexate 12.5mg wkly, Seretode 500 1pbd,Fosamax 70mg once/wk,Folic acid 5mg od,Calchichew,Cocodamol prn | 81 | 65 | female | 1 | 55 | Severe_4 | CD4+ T-cells |
GSM788315 | Prednisolone 5mg od,Montelukast 10mg od,Symbicort 400/12 2pbd,Omeprazole 20mg od,Uniphyllin 400mg bd,Bricanyl prn | 61 | 44 | female | 1 | 54 | Severe_5 | CD4+ T-cells |
GSM788316 | Prednisolone 10-20mg od,Combivent neb 2-4/day,Cetirizine 10mg od,Terbutaline 500mcg od,Budesonide 400mcg 2pbd, Aminophylline SR 450mg bd, Formoterol 12mcg 2pbd | 69 | 55 | female | 1 | 54 | Severe_6 | CD4+ T-cells |
GSM788317 | Prednisolone 10mg od, Insulin S/C,Seretide 500mcg 2pbd, Metformin,Nexium, Flixonase,Tramacet,Calcium,Valsartan,Amitriptyline | 105 | 71 | female | 1 | 45 | Severe_7 | CD4+ T-cells |
GSM788318 | Prednisolone 5mg od, Aminophylline 225mg bd,Seretide 500 2pbd,doxycycline, Tiotropium | 94 | 33 | female | 1 | 42 | Severe_8 | CD4+ T-cells |
GSM788319 | Becotide, Ventolin | 98 | 82 | male | 2 | 23 | Non_severe_1 | CD8+ T-cells |
GSM788320 | flixotide | 92 | 87 | female | 2 | 44 | Non_severe_2 | CD8+ T-cells |
GSM78832 | Becotide, Ventolin | 89 | 77 | male | 2 | 35 | Non_severe_3 | CD8+ T-cells |
GSM788322 | Salbutamol | 81 | 84 | female | 2 | 23 | Non_severe_4 | CD8+ T-cells |
GSM788323 | Flixotide 500mcg 2pbd,Oxis 12 1pbd,Loratadine 1 tab od,Beconase 2pbd | 105 | 82 | female | 1 | 55 | Severe_1 | CD8+ T-cells |
GSM788324 | Prednisolone 8mg - 1mg for 5wks(stopped 30/5/08),seretide 500mcg 1pbd,Singular 10mg bd,Phyllocontin 225mg am 450mg pm,Ventolin prn | 101 | 105 | female | 1 | 21 | Severe_2 | CD8+ T-cells |
GSM788325 | prednisolone 15mg od,Seretide 500mcg 2pbd,Montelukast 10mg nocte,Ventolin prn,Phyllocontin 450mg bd,Flixonase od | 113 | 98 | male | 1 | 32 | Severe_3 | CD8+ T-cells |
GSM788326 | Prednisolone 10mg od,Spiriva 18mcg od,Methotrexate 12.5mg wkly, Seretode 500 1pbd,Fosamax 70mg once/wk,Folic acid 5mg od,Calchichew,Cocodamol prn | 81 | 65 | female | 1 | 55 | Severe_4 | CD8+ T-cells |
GSM788327 | Prednisolone 5mg od,Montelukast 10mg od,Symbicort 400/12 2pbd,Omeprazole 20mg od,Uniphyllin 400mg bd,Bricanyl prn | 61 | 44 | female | 1 | 54 | Severe_5 | CD8+ T-cells |
GSM788328 | Prednisolone 10-20mg od,Combivent neb 2-4/day,Cetirizine 10mg od,Terbutaline 500mcg od,Budesonide 400mcg 2pbd, Aminophylline SR 450mg bd, Formoterol 12mcg 2pbd | 69 | 55 | female | 1 | 54 | Severe_6 | CD8+ T-cells |
GSM788329 | Prednisolone 10mg od, Insulin S/C,Seretide 500mcg 2pbd, Metformin,Nexium, Flixonase,Tramacet,Calcium,Valsartan,Amitriptyline | 105 | 71 | female | 1 | 45 | Severe_7 | CD8+ T-cells |
GSM788330 | Prednisolone 5mg od, Aminophylline 225mg bd,Seretide 500 2pbd,doxycycline, Tiotropium | 94 | 33 | female | 1 | 42 | Severe_8 | CD8+ T-cells |
GSM78833 | None | 76 | 78 | male | 1 | 39 | Control_1 | CD8+ T-cells |
GSM788332 | None | 107 | 103 | female | 1 | 25 | Control_2 | CD8+ T-cells |
GSM788333 | None | 115 | 105 | female | 1 | 26 | Control_3 | CD8+ T-cells |
GSM788334 | None | 105 | 92 | male | 1 | 46 | Control_4 | CD8+ T-cells |
GSM788335 | None | 77 | 78 | male | 1 | 33 | Control_5 | CD8+ T-cells |
GSM788336 | None | 115 | 116 | female | 1 | 33 | Control_6 | CD8+ T-cells |
GSM788337 | None | 96 | 85 | female | 1 | 31 | Control_7 | CD8+ T-cells |
GSM788338 | None | 111 | 111 | male | 1 | 56 | Control_8 | CD8+ T-cells |